Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Philippe Moreau(Hotel Dieu Hospital), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Joseph Mıkhael(Translational Genomics Research Institute), Kwee Yong(University College Hospital), Marcelo Capra(Hospital Mãe de Deus), Thierry Façon(Université de Lille), Roman Hájek(University of Ostrava), Ivan Špıčka(Charles University), Ross Baker(Murdoch University), Kihyun Kım(Samsung Medical Center), Gracia Martınez(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Chang‐Ki Min, Luděk Pour(University Hospital Brno), Xavier Leleu(Inserm), Albert Oriol(Institut Català d'Oncologia), Youngil Koh(Seoul National University Hospital), Kenshi Suzuki(Japanese Red Cross Medical Center), Marie‐Laure Risse(Sanofi (France)), Gaëlle Asset(Sanofi (France)), Sandrine Macé(Sanofi (France)), Thomas G. Martin(University of California, San Francisco), Philippe Moreau(Hotel Dieu Hospital), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Joseph Mıkhael(Translational Genomics Research Institute), Kwee Yong(University College Hospital), Marcelo Capra(Hospital Mãe de Deus), Thierry Façon(Université de Lille), Roman Hájek(University of Ostrava), Ivan Špıčka(Charles University), Ross Baker(Murdoch University), Kim Kihyun(Samsung Medical Center), Gracia Martınez(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Min Chang‐Ki, Luděk Pour(University Hospital Brno), Xavier Leleu(Inserm), Albert Oriol(Institut Català d'Oncologia), Koh Youngil(Seoul National University Hospital), Kenshi Suzuki(Japanese Red Cross Medical Center), Tom Martin(University of California, San Francisco), Hang Quach, Andrew Lim, Helen Crowther, Hanlon Sia, Cyrille Hulin, Mohamad Mohty, Gábor Mikala, Zsolt Nagy, Marta Reinoso Segura, Laura Rosiñol, Münci Yağcı, Mehmet Turgut, Mamta Garg, Gurdeep Parmar, Brad Augustson, Nelson Castro, Edvan de Queiroz Crusoé, Tomáš Pika, Sosana Delimpasi, Kenichi Ishizawa, Anup George, Т. С. Константинова, Javier de la Rubia, Kim Sung-Hyun(Japanese Red Cross Medical Center), Ângelo Maiolino, Tony Reiman, Richard LeBlanc, Shigeki Ito, Junji Tanaka, А. С. Лучинин, I. V. Kryuchkova, Joaquín Martínez‐López(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Jesse Shustik, Lionel Karlin, Anargyros Symeonidis, Miklós Egyed, Mario Petrini, Michèle Cavo, Michihiro Uchiyama, Hilary Blacklock, Mutlu Arat, James E. Griffin, Hannah Hunter, Tonda Buck, Αchilles Anagnostopoulos, Κωνσταντίνος Κωνσταντόπουλος, Tamás Masszi, Sara Bringhen, Barbara Gamberi, Yawara Kawano, Kim Jin Seok(Japanese Red Cross Medical Center), Hakan Özdoğu, Fahir Özkalemkaş
Cited by 377
Abstract
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al.|JNCI Journal of the National Cancer Institute|1993|15.9k
EuroQol - a new facility for the measurement of health-related quality of life
|Health Policy|1990|15.8k